[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/sci/ - Science & Math

Search:


View post   

>> No.14729261 [View]
File: 55 KB, 791x475, Paxlovid.png [View same] [iqdb] [saucenao] [google]
14729261

>>14729176
>the research they performed didn't have a goal to compare vaccinated and unvaccinated, the goal was to compare delta with omicron.
I find it interesting that there's no studies evaluating viral clearance in unvaccinated and vaccinated post-Omicron. It's almost like they abandoned looking into it once the vaccines failed to show a benefit. The only study I can find sort of looking at it was looking directly at viral load for the first five days, and showed only a mild benefit if boosted, and none in the double vaccinated. It would have been more revealing if they continued following until everyone (or nearly everyone) had cleared the virus.

>i have no idea what's that about, didn't really follow the covid recently, any links to research?
There's the original study that gained it approval, which again, dropped the vaccinated arm without explanation. Then Israel studied it and stated an overall benefit, but when looking at vaccination status (or what they call "prior immunity," and in this case, a single dose of the vaccine counted as no immunity), the risk was by far the lowest in the unvaccinated group who received Paxlovid.

https://www.researchsquare.com/article/rs-1705061/v1

Navigation
View posts[+24][+48][+96]